National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
NCI Home Cancer Topics Clinical Trials Cancer Statistics Research & Funding News About NCI
IN THIS ISSUE
Turning Molecules into Medicine

Translational Science

Animation/VideoAnimation/Video

Audio ClipsAudio Clips

Photos/StillsPhotos/Stills

USEFUL CANCER BACKGROUND
Understanding Cancer Series
Show-and-Tell Tutorials

------

NCI Fact Sheets
Briefs on Cancer Topics

------

NewsCenter
Press Releases

------
SEARCH BENCHMARKS
   
  Between these Dates:      
     
     
Search Benchmarks  
    View All Issues  

MEDIA RESOURCES
Noticias En EspaƱol

Understanding Cancer Series

Visuals Online

B-Roll Footage

Radio Broadcasts

Entertainment Resources

Go To Benchmarks Home Page...
Benchmarks
------
Volume 6, Issue 1
------
Audio

TRANSCRIPT: Dr. Ernie Hawk, M.D., leader of NCI's TRWG (Translational Research Working Group), discusses two aspects of translational research:


"We on the TRWG have identified probably five pathways. One would be agent development that we just discussed. Another would be lifestyle modulation recommendations. So stopping tobacco, increasing physical activity, using dietary restrictions, etc. Another would be development of devices to assess risk. Another would be development of devices to intervene, so better biopsy probes or heat probes, that could be used to treat cancer or prevent it. So there are four or five different ways that we're seeing as developmental things that get within translational science."


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov